Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer: A Guidelines and Case-Based Discussion

Elevate Care in Advanced Prostate Cancer: A Non-CME Lunch Symposium supported by Astellas Pharma US, Inc.

Speaker(s)

• SS

  Scott Sellinger

Oligometastatic M1 HSPC

High Risk Patient (Genetic Testing)

M0 CRPC – Index Patient 1 (slow PSAdt)

M0 CRPC – Index Patient 1 (rapid PSAdt)